Royal Infirmary of Edinburgh Clinical Research Facility
Edinburgh, EH16 4SA, United Kingdom
NCT Number: NCT01812317
Fire-fighters are at increased risk of death from heart attacks when compared to other emergency service professionals whose jobs involve similar components such as emergency call-outs and shift work. The unique risk to fire-fighters is likely to reflect a combination of factors including extreme physical exertion, mental stress, heat and pollutant exposure.
In the largest analysis of cause of death amongst on-duty fire-fighters, fire-fighter deaths were classified according to the duty performed during the onset of symptoms or immediately prior to any sudden death. The majority of deaths due to a cardiovascular cause (i.e. heart attack) occurred during fire-suppression whilst this activity represented a relatively small amount of a fire-fighters professional time. Fire simulation training centers offer a unique opportunity to assess the heart, blood and blood vessel response to fire suppression in a controlled environment.
In this study the investigators will assess healthy career fire-fighters on two occasions: following a fire-suppression training exercise in a purpose built real-fire training center, and following a sedentary period as a control. The investigators will take blood samples to measure platelet activity (platelets are the particles in blood that help blood clot) and will examine how blood clots outside of the body. The investigators will then perform studies placing small needles in the arm to assess blood vessel function following fire suppression. By undertaking this comprehensive assessment of blood, blood vessel and heart function we hope to understand the mechanisms whereby the risk of a heart attack is influenced by fire suppression. The investigators hypothesize that following the fire-suppression exercise firefighters blood will clot more readily and their blood vessels will not relax properly which are two of the main processes in the development of a heart attack.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Edinburgh, EH16 4SA, United Kingdom
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Forearm venous occlusion plethysmography to measure forearm blood flow during intra-arterial infusion of the vasodilators Verapamil (10-100 µg/min), bradykinin (100-1000 pmol/min), sodium nitroprusside (2-8 µg/min) and Acetylcholine (5-20 µg/min).
Other names: BK, SNP, ACh, VP
Ex-vivo assessment of thrombus formation using the Badimon Chamber
Time frame: 3-6 hours post exposure
Time frame: 2 hours post exposure
Time frame: During forearm study, 3-6 hours post exposure
University of Edinburgh
Other
Acronym: FIREPROOF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01813032
Atherothrombosis, Cardiovascular Diseases
Edinburgh, United Kingdom
View Trial DetailsNCT01805063
Atherothrombosis, Cardiovascular Diseases
Edinburgh, United Kingdom
View Trial DetailsNCT04550026
Blood Markers, Cardiovascular Diseases
Danderyd, Stockholm County, Sweden
View Trial DetailsNCT01495325
Cardiovascular Diseases, Embolism and Thrombosis
Umeå, Västerbotten County, Sweden
View Trial Details